Seven Days Antibiotics OK for HAP/ VAP, New Guidelines
The guidelines recommend that hospitals develop an antibiogram, a regular analysis of the strains of bacteria causing pneumonia infections locally to ensure the optimal choice of antibiotics. The antibiogram should be specific to ICU patients and updated regularly, with the most appropriate frequency being determined by the hospital. The other differences with the 2005 guideline are the use of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology for the evaluation of evidence and removal of the concept of healthcare-associated pneumonia (HCAP).
The guidelines are published in the journal Clinical Infectious Diseases and were developed by a multidisciplinary panel that included infectious diseases, pulmonary and critical care specialists.
See Also: Closer Collaboration Between Nurses and Physicians May Minimise VAP Risk
Andre C. Kalil, MD, MPH, lead author of the guidelines, professor of medicine in the Division of Infectious Diseases and director of the Transplant Infectious Diseases Program at the University of Nebraska Medical Center, Omaha in a statement said that once clinicians are regularly updated on the bacteria involved, and sensitivities to specific antibiotics, they can choose the most effective treatment.
"This helps individualise care, ensuring patients will be treated with the correct antibiotic as soon as possible,” he added.
Source: Infectious Diseases Society of America (IDSA)
Image credits: IDSA (top); University of Nebraska Medical Center
Supplemental material is available on the IDSA website.
Published on : Tue, 19 Jul 2016
Print as PDF
Get an complete overview of your POCT setup - from one dashboard Your point-of-care-testing setup probably involves many different types of devices from various manufacturers. Radiometer's AQURE point-of-care management system can give you an overview...
Medos customized tubing sets have been individually designed, so that all customer requirements, depending on application and need can be realized. Furthermore tubing sets can be refined by rheoparin or x.eed coating.
The HAMILTON-C3 ventilator is a modular high-end ventilation solution for all patient groups. Offering a number of unique features, the HAMILTON-C3 is one of the first ventilators featuring the “Ventilation Autopilot” INTELLiVENT-ASV®. The HAMILTON-C3’s...
Monitor vital signs of sensitive patients with reliable, smart and intuitive technology Not available in the US Sensitive patients, like neonates, require comfortable care. With transcutaneous monitoring, you can easily keep track of the oxygenation...
XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering lung...